摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-[2-(二乙氨基)乙基]-1,3-二甲基黄嘌呤 | 314-35-2

中文名称
7-[2-(二乙氨基)乙基]-1,3-二甲基黄嘌呤
中文别名
依他茶碱
英文名称
7-[2-(diethylamino)ethyl]theophylline
英文别名
etamiphylline;Diethylaminoethyl-theophyllin;7-(2-diethylamino-ethyl)-1,3-dimethyl-3,7-dihydro-purine-2,6-dione;7-(2-Diaethylamino-aethyl)-1,3-dimethyl-3,7-dihydro-purin-2,6-dion;7-[2-(diethylamino)ethyl]-1,3-dimethylpurine-2,6-dione
7-[2-(二乙氨基)乙基]-1,3-二甲基黄嘌呤化学式
CAS
314-35-2
化学式
C13H21N5O2
mdl
——
分子量
279.342
InChiKey
AWKLBIOQCIORSB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    75°
  • 沸点:
    422.11°C (rough estimate)
  • 密度:
    1.1155 (rough estimate)
  • 物理描述:
    Solid

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    20
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    61.7
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933990090

SDS

SDS:1398f3621c1d612accd45744771e3fdd
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Drug production using non-cross reactive antibodies
    申请人:SYNBIOTICS CORPORATION
    公开号:EP0390612A1
    公开(公告)日:1990-10-03
    A method for producing low molecular weight compounds, which are capable of binding to a naturally occurring receptor and which can be used as drugs and which mimic the three dimensional surface structure of antibodies to drug molecules, are produced by first generating a non-cross reactive antibody to a drug and then producing a low molecular weight structural mimic of the antibody.
    一种生产低分子量化合物的方法,这些化合物能够与自然存在的受体结合,可用作药物,并且模仿抗体对药物分子的三维表面结构。这些化合物首先通过生成对药物的非交叉反应性抗体,然后生产出模仿抗体的低分子量结构模拟物。
  • Sun protection compositions comprising semi-crystalline polymers and hollow latex particles
    申请人:Candau Didier
    公开号:US20090041691A1
    公开(公告)日:2009-02-12
    Topically applicable cosmetic/dermatological UV protection compositions having enhanced SPF contain at least one organic UV screening agent and/or at least one inorganic screening agent, such compositions also containing at least the following constituents (A) and (B): A) a semi-crystalline polymer which is solid at ambient temperature and has a melting point of greater than or equal to 30° C., containing a) a polymeric backbone and b) at least one crystallizable organic side chain and/or one crystallizable organic block forming part of the backbone of this said polymer, said polymer having a number-average molecular mass Mn of greater than or equal to 1,000, and B) hollow latex particles having a particle size ranging from 150 to 380 nm, formulated into a topically applicable, physiologically acceptable medium therefor.
    具有增强SPF的适用于化妆品/皮肤科的防紫外线保护组合物至少包含一种有机紫外线过滤剂和/或至少一种无机过滤剂,此类组合物还至少包含以下成分(A)和(B): A)半结晶聚合物,室温下为固体,熔点大于或等于30°C,包含a)聚合骨架和b)至少一种可结晶有机侧链和/或作为该聚合物骨架一部分的可结晶有机块,该聚合物具有大于或等于1,000的数均分子质量Mn,以及 B)中空乳胶颗粒,粒径范围为150至380纳米,配制成适用于局部使用的、生理上可接受的介质。
  • Substituted theophylline compounds
    申请人:Fisons Limited
    公开号:US04299832A1
    公开(公告)日:1981-11-10
    The substituted theophyllines of the formula: ##STR1## (wherein R.sup.1, R.sup.2 and R.sup.3, which may be the same or different, each represent alkyl of 1 to 6 carbon atoms, cycloalkyl of 3 to 7 carbon atoms, phenyl or phenylalkyl of 7 to 10 carbon atoms, each of which may be unsubstituted or substituted by one or more hydroxy groups, alkoxy or alkylthio groups of 1 to 4 carbon atoms, halogen atoms, cyano groups, nitro groups, carboxy groups, alkoxycarbonyl groups of 2 to 5 carbon atoms, amino groups, alkylamino groups of 1 to 4 carbon atoms or dialkylamino groups of 2 to 8 carbon atoms, or when the group is phenyl or phenylalkyl, by one or more alkyl groups of 1 to 4 carbon atoms; or R.sup.2 and R.sup.3 together represent a hydrocarbon chain of 3 to 6 carbon atoms optionally interrupted by a heteroatom; and n represents an integer of from 1 to 6) and the acid additional salts thereof, are novel compounds which are useful in the treatment of cardiac disorders. Processes for their preparation and pharmaceutical compositions containing them are also described.
    该公式的替代茶碱为:##STR1##(其中R.sup.1、R.sup.2和R.sup.3,可能相同也可能不同,分别代表1至6个碳原子的烷基,3至7个碳原子的环烷基,7至10个碳原子的苯基或苯基烷基,每个基未取代或被一个或多个羟基、烷氧基或硫代烷基、卤素原子、氰基、硝基、羧基、2至5个碳原子的烷氧羰基、氨基、1至4个碳原子的烷基氨基或2至8个碳原子的二烷基氨基取代,或当该基为苯基或苯基烷基时,被一个或多个1至4个碳原子的烷基取代;或R.sup.2和R.sup.3一起代表一个由3至6个碳原子的烃链组成,可选地由一个杂原子中断;n代表1至6的整数),以及其酸的附加盐,是在治疗心脏疾病中有用的新化合物。还描述了它们的制备方法和含有它们的药物组合物。
  • Cosmetic/sunscreen compositions containing dibenzoylmethane compounds and dithiolane compound photostabilizers therefor
    申请人:Lucet-Levannier Karine
    公开号:US20100086502A1
    公开(公告)日:2010-04-08
    Cosmetic/sunscreen compositions contain a combination of at least one dibenzoylmethane sunscreen compound and a photostabilizing amount of at least one dithiolane compound of formula (I) below:
    化妆品/防晒霜组合物含有至少一种二苯甲酮类防晒剂化合物和至少一种式(I)所示的二硫杂环化合物的光稳定量。
  • Artificially coloring the skin with a carotene compound, a xanthophyll compound and a lipophilic green dye composition
    申请人:Cassin Guillaume
    公开号:US20100150853A1
    公开(公告)日:2010-06-17
    A method for artificially coloring the skin entails topical application thereon of a composition containing, formulated into a physiologically acceptable medium: a) at least one compound of the carotene type, b) at least one compound of the xanthophyll type, c) at least one lipophilic green dye; the composition advantageously includes a mixture of dyes including: a) at least one compound of the carotene type, b) at least astaxanthin, c) at least one lipophilic green dye.
    一种人工着色皮肤的方法包括在皮肤上局部涂抹一种含有以下成分的组合物,配制成生理可接受的介质:a) 至少一种类胡萝卜素的化合物,b) 至少一种黄色素类的化合物,c) 至少一种亲脂性绿色染料;该组合物优选包括一种混合染料,其中包括:a) 至少一种类胡萝卜素的化合物,b) 至少一种虾青素,c) 至少一种亲脂性绿色染料。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台